Charles River Laboratories Inte (CRL) Financials
CRL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 8.2 billion | 4.5 billion |
2023-09-30 | 7.6 billion | 4.3 billion |
2023-06-30 | 7.8 billion | 4.5 billion |
2023-03-31 | 7.7 billion | 4.5 billion |
CRL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 142.6 million | 19.5 million |
2023-09-30 | 139.5 million | 22.8 million |
2023-06-30 | 80.7 million | 16.3 million |
2023-03-31 | 2.5 million | 13.5 million |
CRL Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 189.0 million |
2023-09-30 | 88.0 million |
2023-06-30 | 99.4 million |
2023-03-31 | 104.0 million |
CRL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 276.8 million | - | 419.2 million |
2023-09-30 | 157.2 million | 2.5 billion | 390.4 million |
2023-06-30 | 200.4 million | 2.7 billion | 401.6 million |
2023-03-31 | 201.6 million | 2.7 billion | 418.2 million |
CRL Shares Outstanding
CRL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 78.3 million | - | 197.1 million | - |
2023-09-30 | 65.9 million | - | 176.1 million | - |
2023-06-30 | 67.4 million | - | 199.8 million | - |
2023-03-31 | 106.9 million | - | 174.8 million | - |
CRL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.0 billion | 649.4 million |
2023-09-30 | 1.0 billion | 664.8 million |
2023-06-30 | 1.1 billion | 661.0 million |
2023-03-31 | 1.0 billion | 651.7 million |
CRL
Price: $233.47
52 week price:
Earnings Per Share: 9.22 USD
P/E Ratio: 23.66
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 411300
Ebitda: 110.3 millionMarket Capitalization: 12.9 billion
Average Dividend Frequency: 11